Search our site

Common search terms

  • Portfolio
  • Animal Models
  • Proteomics
  • Genome sequencing
  • Portfolio'
Logo: EMBLEM Technology Transfer GmbH
  • Home
  • Company
    • About EMBLEM
    • Team
    • Vacancies
    • Contact
    • Partners
    • Portfolio Companies
  • Inventors
  • Industry
  • Technologies
  • News & Events
    • Latest News
    • Upcoming Events
  • Software
  1. Home
  2. Latest News
  3. Page 11

Latest News

The Pan-Cancer project

The Pan-Cancer project

  • February 10, 2020
  • General

Read more

New EMBL spinoff company Araxa Biosciences

New EMBL spinoff company Araxa Biosciences

  • January 22, 2020
  • General

Read more

EMBL spinoff Velabs and alytas enter into a licence agreement for senescence

EMBL spinoff Velabs and alytas enter into a licence agreement for senescence

  • January 7, 2020
  • General

Read more

Faster, cheaper and more detailed

Faster, cheaper and more detailed

  • December 23, 2019
  • General

Read more

Open Targets Highlights 2019

Open Targets Highlights 2019

  • December 12, 2019
  • General

Read more

EMBL and Leica sign open innovation agreement

EMBL and Leica sign open innovation agreement

  • December 2, 2019
  • General

Read more

Photo-micropatterning advances structural cell biology

Photo-micropatterning advances structural cell biology

  • November 25, 2019
  • General

Read more

Convention on the Rights of the Child stored in DNA

Convention on the Rights of the Child stored in DNA

  • November 13, 2019
  • General

Read more

EMBL spins the Sleeping Beauty transposase

EMBL spins the Sleeping Beauty transposase

  • November 5, 2019
  • General

Read more

Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity

Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity

  • September 3, 2019
  • General

Read more

View more news
Press Contact

Dr. Laurène Ramos Martins

Business Development

  • Email
  • +49 6221 / 363-2210
Categories
  • All Categories
  • General
Archives
Meet EMBLEM
  • There are no upcoming events at this time
  • View all upcoming events

Learn more about EMBLEM

  • About EMBLEM

    About EMBLEM

     About EMBLEM

    EMBLEM, founded in 1999, is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of the European Molecular Biology Laboratory (EMBL).

  • Contact

    Contact

     Contact

    Contact us using info@embl-em.de. Our office is located at Boxbergring 107, 69126 Heidelberg, Germany

EMBLEM Technology Transfer GmbH

Boxbergring 107
D-69126 Heidelberg
Germany

Tel.: +49 (0) 6221 363 22 10
Fax: +49 (0) 6221 363 22 29
Email: info@embl-em.de

Related Organisations
  • EMBL
  • EMBL VENTURES
  • HEIDELBERG STARTUP PARTNERS E.V.
Quick Links
  • Home
  • About EMBLEM
  • Contact us
  • Latest News
  • Upcoming Events

© 2025 EMBLEM. All rights reserved. GBT · Disclaimer and General Conditions of Use · Privacy Policy · Edit Cookie Settings · Imprint

INNOVATION WORKS®